{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:47:10Z","timestamp":1760204830095},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ygyno.2015.06.022","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T08:16:24Z","timestamp":1434701784000},"page":"526-531","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology"],"prefix":"10.1016","volume":"138","author":[{"given":"David","family":"Ly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat Andrew","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Sause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.06.022_bb0005","series-title":"SEER Stat Fact Sheets: Endometrial Cancer","author":"SEER","year":"2015"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0010","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0015","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0360-3016(03)00753-3","article-title":"Outcome and pattern of failure in pathologic stage I\u2013II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy","volume":"57","author":"Mehta","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0035","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2004.01.014","article-title":"Pathologic stage I\u2013II endometrial carcinoma in the elderly: radiotherapy indications and outcome","volume":"59","author":"Citron","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I\u2013II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer\u2014a clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I\u2013II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO Grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3802\/jgo.2013.24.2.120","article-title":"A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system","volume":"24","author":"Kim","year":"2013","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","article-title":"The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer","volume":"85","author":"Barney","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2012.12.026","article-title":"Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer","volume":"129","author":"Townamchai","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0080","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0085","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijgo.2014.06.022","article-title":"Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry","volume":"127","author":"Katsoulakis","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0095","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.06.022_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3802\/jgo.2015.26.1.19","article-title":"The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry","volume":"26","author":"Mattes","year":"2015","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0105","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.06.022_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T09:19:09Z","timestamp":1566897549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0090825815300433"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.022","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}